HWK-016, MUCIN-16-targeted ADC
HWK-016-101
Phase 1 small_molecule active
Quick answer
HWK-016, MUCIN-16-targeted ADC for PROC is a Phase 1 program (small_molecule) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- PROC
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active